Literature DB >> 17079324

Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses.

Reed S Shabman1, Thomas E Morrison, Christopher Moore, Laura White, Mehul S Suthar, Linda Hueston, Nestor Rulli, Brett Lidbury, Jenny P-Y Ting, Suresh Mahalingam, Mark T Heise.   

Abstract

Dendritic cells (DCs) are an important early target cell for many mosquito-borne viruses, and in many cases mosquito-cell-derived arboviruses more efficiently infect DCs than viruses derived from mammalian cells. However, whether mosquito-cell-derived viruses differ from mammalian-cell-derived viruses in their ability to induce antiviral responses in the infected dendritic cell has not been evaluated. In this report, alphaviruses, which are mosquito-borne viruses that cause diseases ranging from encephalitis to arthritis, were used to determine whether viruses grown in mosquito cells differed from mammalian-cell-derived viruses in their ability to induce type I interferon (IFN) responses in infected primary dendritic cells. Consistent with previous results, mosquito-cell-derived Ross River virus (mos-RRV) and Venezuelan equine encephalitis virus (mos-VEE) exhibited enhanced infection of primary myeloid dendritic cells (mDCs) compared to mammalian-cell-derived virus preparations. However, unlike the mammalian-cell-derived viruses, which induced high levels of type I IFN in the infected mDC cultures, mos-RRV and mos-VEE were poor IFN inducers. Furthermore, the poor IFN induction by mos-RRV contributed to the enhanced infection of mDCs by mos-RRV. These results suggest that the viruses initially delivered by the mosquito vector differ from those generated in subsequent rounds of replication in the host, not just with respect to their ability to infect dendritic cells but also in their ability to induce or inhibit antiviral type I IFN responses. This difference may have an important impact on the mosquito-borne virus's ability to successfully make the transition from the arthropod vector to the vertebrate host.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079324      PMCID: PMC1797231          DOI: 10.1128/JVI.01590-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis.

Authors:  Kate D Ryman; Laura J White; Robert E Johnston; William B Klimstra
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

2.  Transcription of the interferon gamma (IFN-gamma )-inducible chemokine Mig in IFN-gamma-deficient mice.

Authors:  S Mahalingam; G Chaudhri; C L Tan; A John; P S Foster; G Karupiah
Journal:  J Biol Chem       Date:  2000-10-09       Impact factor: 5.157

3.  Loss of type I IFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells.

Authors:  Maria Cristina Gauzzi; Irene Canini; Pierre Eid; Filippo Belardelli; Sandra Gessani
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

4.  Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis.

Authors:  G H MacDonald; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.

Authors:  L J White; J G Wang; N L Davis; R E Johnston
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Potentiation of vesicular stomatitis New Jersey virus infection in mice by mosquito saliva.

Authors:  K H Limesand; S Higgs; L D Pearson; B J Beaty
Journal:  Parasite Immunol       Date:  2000-09       Impact factor: 2.280

7.  Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.

Authors:  Washington B Cárdenas; Yueh-Ming Loo; Michael Gale; Amy L Hartman; Christopher R Kimberlin; Luis Martínez-Sobrido; Erica Ollmann Saphire; Christopher F Basler
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

8.  Human skin Langerhans cells are targets of dengue virus infection.

Authors:  S J Wu; G Grouard-Vogel; W Sun; J R Mascola; E Brachtel; R Putvatana; M K Louder; L Filgueira; M A Marovich; H K Wong; A Blauvelt; G S Murphy; M L Robb; B L Innes; D L Birx; C G Hayes; S S Frankel
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

9.  Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.

Authors:  Friedemann Weber; Anne Bridgen; John K Fazakerley; Hein Streitenfeld; Nina Kessler; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction.

Authors:  A Dzionek; Y Sohma; J Nagafune; M Cella; M Colonna; F Facchetti; G Günther; I Johnston; A Lanzavecchia; T Nagasaka; T Okada; W Vermi; G Winkels; T Yamamoto; M Zysk; Y Yamaguchi; J Schmitz
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  52 in total

1.  Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages.

Authors:  Karine Labadie; Thibaut Larcher; Christophe Joubert; Abdelkrim Mannioui; Benoit Delache; Patricia Brochard; Lydie Guigand; Laurence Dubreil; Pierre Lebon; Bernard Verrier; Xavier de Lamballerie; Andreas Suhrbier; Yan Cherel; Roger Le Grand; Pierre Roques
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Host alternation of chikungunya virus increases fitness while restricting population diversity and adaptability to novel selective pressures.

Authors:  Lark L Coffey; Marco Vignuzzi
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

3.  Arbovirus evolution in vivo is constrained by host alternation.

Authors:  Lark L Coffey; Nikos Vasilakis; Aaron C Brault; Ann M Powers; Frédéric Tripet; Scott C Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-05       Impact factor: 11.205

4.  Western Equine Encephalitis submergence: lack of evidence for a decline in virus virulence.

Authors:  Naomi L Forrester; Joan L Kenney; Eleanor Deardorff; Eryu Wang; Scott C Weaver
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

5.  Noncapped Alphavirus Genomic RNAs and Their Role during Infection.

Authors:  K J Sokoloski; K C Haist; T E Morrison; S Mukhopadhyay; R W Hardy
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

6.  Structural plasticity of the Semliki Forest virus glycome upon interspecies transmission.

Authors:  Max Crispin; David J Harvey; David Bitto; Camille Bonomelli; Matthew Edgeworth; James H Scrivens; Juha T Huiskonen; Thomas A Bowden
Journal:  J Proteome Res       Date:  2014-02-10       Impact factor: 4.466

7.  IPS-1 is essential for the control of West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Daphne Y Ma; Sunil Thomas; Jennifer M Lund; Nu Zhang; Stephane Daffis; Alexander Y Rudensky; Michael J Bevan; Edward A Clark; Murali-Krishna Kaja; Michael S Diamond; Michael Gale
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

8.  Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Authors:  Clémentine Schilte; Thérèse Couderc; Fabrice Chretien; Marion Sourisseau; Nicolas Gangneux; Florence Guivel-Benhassine; Anton Kraxner; Jürg Tschopp; Stephen Higgs; Alain Michault; Fernando Arenzana-Seisdedos; Marco Colonna; Lucie Peduto; Olivier Schwartz; Marc Lecuit; Matthew L Albert
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

9.  Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice.

Authors:  Kristin M Long; Alan C Whitmore; Martin T Ferris; Gregory D Sempowski; Charles McGee; Bianca Trollinger; Bronwyn Gunn; Mark T Heise
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

10.  N-linked glycans on dengue viruses grown in mammalian and insect cells.

Authors:  Kari Hacker; Laura White; Aravinda M de Silva
Journal:  J Gen Virol       Date:  2009-06-03       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.